Morgan Dempsey Capital Management’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-896
| Closed | -$75.5K | – | 124 |
|
|
2023
Q4 | $75.5K | Hold |
896
| – | – | 0.02% | 56 |
|
|
2023
Q3 | $77.1K | Buy |
896
+3
| +0.3% | +$277 | 0.02% | 55 |
|
|
2023
Q2 | $83.2K | Sell |
893
-5,000
| -85% | -$471K | 0.02% | 56 |
|
|
2023
Q1 | $558K | Buy |
+5,893
| New | +$542K | 0.15% | 42 |
|
|
2021
Q2 | – | Sell |
-1,203
| Closed | -$104K | – | 104 |
|
|
2021
Q1 | $104K | Buy |
1,203
+454
| +61% | +$39.9K | 0.03% | 50 |
|
|
2020
Q4 | $63K | Sell |
749
-58
| -7% | -$4.95K | 0.03% | 62 |
|
|
2020
Q3 | $64K | Sell |
807
-116
| -13% | -$9.63K | 0.02% | 71 |
|
|
2020
Q2 | $82K | Sell |
923
-110
| -11% | -$9.88K | 0.03% | 64 |
|
|
2020
Q1 | $97K | Sell |
1,033
-893
| -46% | -$83K | 0.05% | 53 |
|
|
2019
Q4 | $208K | Sell |
1,926
-8,083
| -81% | -$819K | 0.08% | 46 |
|
|
2019
Q3 | $959K | Sell |
10,009
-834
| -8% | -$77.5K | 0.35% | 42 |
|
|
2019
Q2 | $1.04M | Sell |
10,843
-573
| -5% | -$48.2K | 0.39% | 45 |
|
|
2019
Q1 | $1.01M | Sell |
11,416
-624
| -5% | -$54.9K | 0.4% | 48 |
|
|
2018
Q4 | $1M | Sell |
12,040
-273
| -2% | -$24K | 0.44% | 46 |
|
|
2018
Q3 | $1.16M | Sell |
12,313
-73
| -0.6% | -$6.97K | 0.45% | 47 |
|
|
2018
Q2 | $1.36M | Sell |
12,386
-1,251
| -9% | -$131K | 0.54% | 40 |
|
|
2018
Q1 | $1.35M | Sell |
13,637
-13,375
| -50% | -$1.19M | 0.53% | 40 |
|
|
2017
Q4 | $2.2M | Sell |
27,012
-1,239
| -4% | -$96.7K | 0.71% | 44 |
|
|
2017
Q3 | $2.07M | Buy |
28,251
+787
| +3% | +$56.6K | 0.7% | 44 |
|
|
2017
Q2 | $1.99M | Sell |
27,464
-826
| -3% | -$54.4K | 0.72% | 45 |
|
|
2017
Q1 | $1.76M | Sell |
28,290
-21,064
| -43% | -$1.33M | 0.67% | 51 |
|
|
2016
Q4 | $3.59M | Buy |
49,354
+79
| +0.2% | +$5.14K | 1.03% | 29 |
|
|
2016
Q3 | $2.95M | Sell |
49,275
-9,492
| -16% | -$604K | 0.99% | 35 |
|
|
2016
Q2 | $3.7M | Sell |
58,767
-12,738
| -18% | -$822K | 1.25% | 14 |
|
|
2016
Q1 | $4.47M | Sell |
71,505
-31,283
| -30% | -$1.84M | 1.6% | 9 |
|
|
2015
Q4 | $6.02M | Sell |
102,788
-23,045
| -18% | -$1.31M | 2.31% | 7 |
|
|
2015
Q3 | $6.78M | Sell |
125,833
-45,364
| -26% | -$2.47M | 2.4% | 7 |
|
|
2015
Q2 | $10.2M | Sell |
171,197
-9,540
| -5% | -$537K | 2.82% | 8 |
|
|
2015
Q1 | $10.8M | Sell |
180,737
-7,995
| -4% | -$470K | 2.84% | 8 |
|
|
2014
Q4 | $11.3M | Sell |
188,732
-30,655
| -14% | -$1.7M | 2.93% | 8 |
|
|
2014
Q3 | $10.7M | Buy |
219,387
+12,458
| +6% | +$633K | 2.51% | 10 |
|
|
2014
Q2 | $10.6M | Buy |
206,929
+9,434
| +5% | +$484K | 2.36% | 10 |
|
|
2014
Q1 | $11.4M | Buy |
197,495
+31,932
| +19% | +$1.74M | 2.83% | 7 |
|
|
2013
Q4 | $9.46M | Sell |
165,563
-30,512
| -16% | -$1.67M | 2.95% | 8 |
|
|
2013
Q3 | $11.7M | Buy |
196,075
+6,412
| +3% | +$350K | 4.05% | 3 |
|
|
2013
Q2 | $10.3M | Buy |
+189,663
| New | +$8.93M | 3.92% | 3 |
|
Other funds holding UTMD
RIM
BIP
Morgan Dempsey Capital Management's UTMD Position: Q1 2024 in Review
Morgan Dempsey Capital Management sold out of Utah Medical Products (UTMD) in Q1 2024, closing a stake of 896 shares — an estimated $75.5K sold.
Morgan Dempsey Capital Management first reported a position in UTMD in Q2 2013 and held it in 36 quarters. The position peaked at $11.7M in Q3 2013. 100 funds tracked by Wall St. Rank hold UTMD as of Q1 2024.
- Morgan Dempsey Capital Management reported no remaining Utah Medical Products position as of Q1 2024 after selling out during the quarter.
- Morgan Dempsey Capital Management sold 896 Utah Medical Products shares in Q1 2024, an estimated $75.5K.
- Morgan Dempsey Capital Management first reported a position in Utah Medical Products in Q2 2013 and held it in 36 quarters.
- Morgan Dempsey Capital Management's Utah Medical Products position peaked at $11.7M in Q3 2013.
- 100 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2024.
Based on Morgan Dempsey Capital Management's 13F filing for Q1 2024, filed 2 May 2024.